Nguy c sn phm GLP-1 gi v km cht lng 6
Secondly, HCG protocols typically involve severe caloric restriction (500800 kcal/day), which poses significant health risks including: Nutritional deficiencies (vitamins, minerals, essential fatty acids) Muscle loss and reduced metabolic rate Fatigue, dizziness, and electrolyte imbalances Gallstone formation Cardiac arrhythmias in susceptible individuals When combined with Wegovywhich already reduces appetite and food intakethe risk of inadequate nutrition becomes substantially greater
Food and Drug Administration (FDA) indications to match
So the underlying way that GLP-1s work might not target the issue that every person has.' Semaglutide, marketed as Wegovy and its sister drug Ozempic, hasn't worked for about 15 percent of patients taking them, losing less than five percent of their body weight The above graphic shows how weight-loss drug tirzepatide works
Glow will follow
That said, consistency is key